Maria Wigren (Former)
1 – 10 of 36
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Immune responses against oxidized LDL as possible targets for prevention of atherosclerosis in systemic lupus erythematosus
(
- Contribution to journal › Article
- 2019
-
Mark
Elevated circulating effector memory T cells but similar levels of regulatory T cells in patients with type 2 diabetes mellitus and cardiovascular disease
(
- Contribution to journal › Article
-
Mark
Lack of Ability to Present Antigens on Major Histocompatibility Complex Class II Molecules Aggravates Atherosclerosis in ApoE-/- Mice
(
- Contribution to journal › Article
- 2018
-
Mark
IL-1R and MyD88 signalling in CD4+ T cells promote Th17 immunity and atherosclerosis
(
- Contribution to journal › Article
-
Mark
B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice
(
- Contribution to journal › Article
-
Mark
Cardiovascular disease in systemic lupus erythematosus is associated with increased levels of biomarkers reflecting receptor-activated apoptosis
(
- Contribution to journal › Article
- 2017
-
Mark
FADD, Caspase-3, and Caspase-8 and Incidence of Coronary Events
(
- Contribution to journal › Article
-
Mark
Elevated Markers of Death Receptor-Activated Apoptosis are Associated with Increased Risk for Development of Diabetes and Cardiovascular Disease
(
- Contribution to journal › Article
-
Mark
Plasma stem cell factor levels are associated with risk of cardiovascular disease and death
(
- Contribution to journal › Article
-
Mark
Recent advances on CD4+ T cells in atherosclerosis and its implications for therapy
(
- Contribution to journal › Article